Ivermectin Worked: Peer-Reviewed Study Proves It (August 2023)
SUMMARY
A preprint paper showing ivermectin’s effectiveness against COVID-19 in Peru convinced a group of doctors that widespread ivermectin distribution could end the pandemic in October 2020.
Because the paper wasn’t yet peer-reviewed, it was brushed off; ivermectin for COVID-19 was vilified, as were those who dared to prescribe it.
On August 8, 2023, the study has been peer-reviewed and published in Cureus, concluding ivermectin as an effective treatment for COVID-19.
Not only did ivermectin work against COVID-19, it was remarkably effective, resulting in a 74% reduction in excess deaths in the 10 Peru states where it was used most intensively.
There was a 14-fold reduction in nationwide excess deaths when ivermectin was readily available and then a 13-fold increase in excess deaths in the two months after ivermectin use was restricted.
As the COVID pandemic wore on, with potential treatments supposedly unknown, New York pulmonologist Dr. Pierre Kory and others tried to get the word out about ivermectin. A widely used antiparasitic drug that’s listed on the World Health Organization’s essential medicines list1 and approved by the U.S. Food and Drug Administration, ivermectin is widely available, inexpensive and has a long history of safe usage.
In fact, since 1987, 3.7 billion doses of ivermectin have been used among humans worldwide,2 but it was quickly vilified — as were those who dared to prescribe it. Now, the tables have turned. Not only did ivermectin work against COVID-19, it was remarkably effective, resulting in a 74% reduction in excess deaths in the 10 states where it was used most intensively.3
Ivermectin Dramatically Slashed COVID Deaths
Kory and other physicians with the Front Line COVID-19 Critical Care Working Group (FLCCC) had success early on treating patients with ivermectin and other therapies during the pandemic. His efforts to get the word out on this treatment protocol were stifled by censorship, ridicule and colleagues brainwashed by the official narrative and unwilling to accept the science.
A preprint paper showing ivermectin’s effectiveness against COVID-19 in Peru "was the final piece of evidence which convinced me, Paul [Marik] and the FLCCC that widespread ivermectin distribution could end the pandemic in Oct of 2020," Kory tweeted.4 "Took 2 years but now peer-reviewed & published in a major journal."
That study, published in Cureus,5 concludes ivermectin as an effective treatment for COVID-19. "Reductions in excess deaths over a period of 30 days after peak deaths averaged 74% in the 10 states with the most intensive IVM [ivermectin] use," the study found.6 It used Peruvian national health data from Peru’s 25 states to evaluate ivermectin’s effects.
A natural experiment was set in motion in May 2020, when Peru authorized ivermectin for COVID-19. The significant reduction in excess deaths noted "correlated closely with the extent of IVM use," the researchers noted.
Global Success Stories Highlight Ivermectin’s Potential….
https://covid19.onedaymd.com/2023/09/ivermectin-worked-peer-reviewed-study.html